Overview
Specialty chemicals maker's Q4 revenue rose 5% yr/yr
Q4 adjusted EBITDA fell 3%, impacted by lower Surfactant sales volume
Outlook
Stepan expects Project Catalyst to deliver $100 mln in pre-tax savings over two years
Company anticipates full-year adjusted EBITDA growth in 2026
Stepan plans to close Fieldsboro, NJ site as part of Project Catalyst
Result Drivers
SURFACTANT SALES DECLINE - Surfactant sales volume fell 7% due to lower demand in Laundry & Cleaning markets and impact of Philippines divestiture
POLYMER VOLUME GROWTH - Polymer sales volume increased 11%, driven by Rigid and Phthalic Anhydride markets
PRICE INCREASES - Net sales rose 5% due to higher selling prices and favorable product mix
Company press release: ID:nPn6P7QMCa
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Sales
Miss
$553.89 mln
$570.60 mln (2 Analysts)
Q4 Adjusted EPS
Miss
-$0.02
$0.40 (2 Analysts)
Q4 EPS
$0.22
Q4 Adjusted Net Income
-$531,000
Q4 Net Income
$5.004 mln
Q4 Operating Income
$10.50 mln
Analyst Coverage
The one available analyst rating on the shares is "buy"
The average consensus recommendation for the specialty chemicals peer group is "buy"
Wall Street's median 12-month price target for Stepan Co is $75.00, about 11.6% above its February 20 closing price of $67.23
The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 13 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)